These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Clinical relevance of proliferation biomarkers and p53 expression in rectal mucosa and sporadic colonic adenomas: a prospective study. Freitas D; Goulão MH; Camacho E; Figueiredo P; Ministro P; Ferreira M; Portela F; Andrade P; Donato A; Martins MI Hepatogastroenterology; 2002; 49(47):1269-74. PubMed ID: 12239922 [TBL] [Abstract][Full Text] [Related]
3. ß-Catenin, Cox-2 and p53 immunostaining in colorectal adenomas to predict recurrence after endoscopic polypectomy. Brand L; Munding J; Pox CP; Ziebarth W; Reiser M; Hüppe D; Schmiegel W; Reinacher-Schick A; Tannapfel A Int J Colorectal Dis; 2013 Aug; 28(8):1091-8. PubMed ID: 23516071 [TBL] [Abstract][Full Text] [Related]
4. Proliferative activity in colonic adenomas as a predictor of metachronous adenomas as assessed by proliferating cell nuclear antigen immunohistochemistry. Paspatis GA; Karamanolis DG; Vasilakaki T; Zizi A; Xourgias V; Elemenoglou I; Hadziyannis SJ Am J Gastroenterol; 1995 Apr; 90(4):597-602. PubMed ID: 7717318 [TBL] [Abstract][Full Text] [Related]
5. p53 and bcl-2 protein expression in rectosigmoid adenomas. Papatheodoridis GV; Kapranos N; Tzouvala M; Triantafyllou K; Elemenoglou I; Karamanolis DG Am J Gastroenterol; 1998 Jul; 93(7):1136-40. PubMed ID: 9672345 [TBL] [Abstract][Full Text] [Related]
6. Predictors of the early development of advanced metachronous colon adenomas. Triantafyllou K; Papatheodoridis GV; Paspatis GA; Vasilakaki TH; Elemenoglou I; Karamanolis DG Hepatogastroenterology; 1997; 44(14):533-8. PubMed ID: 9164533 [TBL] [Abstract][Full Text] [Related]
7. Adenomas of the colon: overexpression of p53 protein and risk factors. Speroni AH; Vanzulli SI; Meiss RP Endoscopy; 1998 Sep; 30(7):623-6. PubMed ID: 9826142 [TBL] [Abstract][Full Text] [Related]
8. P53 protein immunohistochemical expression in colonic adenomas with and without associated carcinoma. Saleh HA; Aburashed A; Bober P; Tabaczka P Am J Gastroenterol; 1998 Jun; 93(6):980-4. PubMed ID: 9647033 [TBL] [Abstract][Full Text] [Related]
9. P53 and MIB-1 immunohistochemistry as predictors of the clinical behavior of nonfunctioning pituitary adenomas. Hentschel SJ; McCutcheon lE; Moore W; Durity FA Can J Neurol Sci; 2003 Aug; 30(3):215-9. PubMed ID: 12945944 [TBL] [Abstract][Full Text] [Related]
10. Atypical pituitary adenomas: clinical characteristics and role of ki-67 and p53 in prognostic and therapeutic evaluation. A series of 50 patients. Del Basso De Caro M; Solari D; Pagliuca F; Villa A; Guadagno E; Cavallo LM; Colao A; Pettinato G; Cappabianca P Neurosurg Rev; 2017 Jan; 40(1):105-114. PubMed ID: 27215912 [TBL] [Abstract][Full Text] [Related]
11. Utility of MMP-1, p53, E-cadherin, and collagen IV immunohistochemical stains in the differential diagnosis of adenomas with misplaced epithelium versus adenomas with invasive adenocarcinoma. Yantiss RK; Bosenberg MW; Antonioli DA; Odze RD Am J Surg Pathol; 2002 Feb; 26(2):206-15. PubMed ID: 11812942 [TBL] [Abstract][Full Text] [Related]
12. [Significance of p53 protein expression and proliferative potential with MIB-1 on tumor recurrence of pituitary adenomas]. Miyagami M; Nakamura S No To Shinkei; 1998 Jan; 50(1):27-32. PubMed ID: 9493195 [TBL] [Abstract][Full Text] [Related]
13. [Expression of protein p53 in the adenoma-colorectal carcinoma sequence]. Gafà R; Lanza G Pathologica; 1998 Aug; 90(4):351-6. PubMed ID: 9793394 [TBL] [Abstract][Full Text] [Related]
14. An immunohistochemical study of the expression of p53 protein in colon cancer. Kim YW; Lee S; Park JH; Yoon TY; Park YK; Yang MH J Korean Med Sci; 1995 Jun; 10(3):176-82. PubMed ID: 8527043 [TBL] [Abstract][Full Text] [Related]
15. Correlation of Ki-67, p53, and Adnab-9 immunohistochemical staining and ploidy with clinical and histopathologic features of severely dysplastic colorectal adenomas. Sheikh RA; Min BH; Yasmeen S; Teplitz R; Tesluk H; Ruebner BH; Tobi M; Hatfield J; Fligiel S; Lawson MJ Dig Dis Sci; 2003 Jan; 48(1):223-9. PubMed ID: 12645814 [TBL] [Abstract][Full Text] [Related]
16. Comparative evaluation of carcinoembryonic antigen, secretory component, and mucins in index and metachronous adenomas of the colorectum. Griffioen G; Bosman FT; Verspaget HW; Sier KF; Biemond I; Lamers CB Gastroenterology; 1991 Oct; 101(4):919-26. PubMed ID: 1889715 [TBL] [Abstract][Full Text] [Related]
17. The Prognostic Roles of the Ki-67 Proliferation Index, P53 Expression, Mitotic Index, and Radiological Tumor Invasion in Pituitary Adenomas. Hasanov R; Aydoğan Bİ; Kiremitçi S; Erden E; Güllü S Endocr Pathol; 2019 Mar; 30(1):49-55. PubMed ID: 30610566 [TBL] [Abstract][Full Text] [Related]
18. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232 [TBL] [Abstract][Full Text] [Related]
19. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry]. Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical analysis of p53 overexpression in human colonic tumors. Darmon E; Cleary KR; Wargovich MJ Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]